These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36537370)

  • 1. Functional improvement of young children with cerebral palsy treated with integrated/intensive rehabilitation and botulinum toxin injections.
    Bonikowski M; Chrościnska-Krawczyk M; Pyrzanowska W
    Neurol Neurochir Pol; 2023; 57(2):183-188. PubMed ID: 36537370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMFCS level improvement in children with cerebral palsy treated with repeat botulinum toxin injections and intensive rehabilitation: A retrospective study.
    Dursun N; Akyuz M; Gokbel T; Akarsu M; Yilmaz E; Karacan C; Dursun E
    J Pediatr Rehabil Med; 2022; 15(1):107-112. PubMed ID: 35275571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
    Franzén M; Hägglund G; Alriksson-Schmidt A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
    J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
    Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
    Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.
    Pin TW; Elmasry J; Lewis J
    Dev Med Child Neurol; 2013 Apr; 55(4):304-13. PubMed ID: 23095013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy].
    Klochkova OA; Kurenkov AL; Karimova HM; Namazova-Baranova LS; Memedyarov AM; Kuzenkova LM; Bursagova BI
    Vestn Ross Akad Med Nauk; 2014; (9-10):57-63. PubMed ID: 25816644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Botulinum Toxin-A and Goal-Directed Physiotherapy in Children with Cerebral Palsy GMFCS Levels I & II.
    Löwing K; Thews K; Haglund-Åkerlind Y; Gutierrez-Farewik EM
    Phys Occup Ther Pediatr; 2017 Aug; 37(3):268-282. PubMed ID: 27058177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of botulinum toxin injections preceding a comprehensive rehabilitation period for children with spastic cerebral palsy: A cost-effectiveness study.
    Schasfoort F; Dallmeijer A; Pangalila R; Catsman C; Stam H; Becher J; Steyerberg E; Polinder S; Bussmann J
    J Rehabil Med; 2018 Jan; 50(1):22-29. PubMed ID: 28949368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Botulinum Toxin A Injection on Ambulation Capacity in Patients with Cerebral Palsy.
    Çağlar Okur S; Uğur M; Şenel K
    Dev Neurorehabil; 2019 May; 22(4):288-291. PubMed ID: 30095354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use.
    Valentine J; Davidson SA; Bear N; Blair E; Paterson L; Ward R; Forbes D; Elliott C
    BMC Pediatr; 2020 Jan; 20(1):7. PubMed ID: 31906902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation].
    Klochkova OA; Kurenkov AL; Namazova-Baranova LS; Mamed'iarov AM; Zherdev KV
    Vestn Ross Akad Med Nauk; 2013; (11):38-48. PubMed ID: 24640730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years].
    Kurenkov AL; Kuzenkova LM; Fisenko DA; Klochkova OA; Bursagova BI; Chernikov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):36-44. PubMed ID: 32678546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin treatment in children with cerebral palsy: a population-based study in Norway.
    Elkamil AI; Andersen GL; Skranes J; Lamvik T; Vik T
    Eur J Paediatr Neurol; 2012 Sep; 16(5):522-7. PubMed ID: 22325829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multilevel botulinum toxin treatment in severe spastic forms of cerebral palsy (GMFCS IV-V)].
    Kurenkov AL; Klochkova OA; Kuzenkova LM; Bursagova BI; Karimova KM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):57-66. PubMed ID: 33459542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of the ACTIVLIM-CP questionnaire: measuring global activity performance in children with cerebral palsy.
    Paradis J; Arnould C; Thonnard JL; Houx L; Pons-Becmeur C; Renders A; Brochard S; Bleyenheuft Y
    Dev Med Child Neurol; 2018 Nov; 60(11):1178-1185. PubMed ID: 29869417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.